Summary Orthofix International NV (Orthofix) is a medical device company that designs, develops, manufactures and distributes medical devices related to spine and orthopedic.Its solutions include spinal implants; human cellular and tissue based products; non-invasive regenerative stimulation products; external and internal fixation devices; bone cement; and devices for removal of bone cement used to fix artificial implants.
Orthofix markets its products through a network of distributors, sales representatives and its subsidiaries.It has manufacturing facilities in the US and Italy; and administrative and training facilities in the US, Brazil, the UK, France, Germany, Puerto Rico and Italy.
Orthofix is headquartered in the Lewisville, Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Orthofix International N.V. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
Report Scope:
This report analyzes the regulatory framework for the clinical trials of orphan drugs in rare and orphan diseases.The report also analyzes the trends and characteristics of clinical trials conducted on rare diseases from 1999-2018, using information from various sources.
This report covers an overview...
Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End Use, And Segment Forecasts, 2021 - 2028
Pharmacovigilance Market Growth & Trends
The global pharmacovigilance...
Nordic Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Service Provider, By Company Size, By Category, By Product Stage, By Indication, By End-use, By Country, And Segment Forecasts, 2021 - 2028 Nordic Regulatory Affairs Market Growth & Trends The Nordic regulatory...
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028 Healthcare CRO Market Growth & Trends The global healthcare...
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
The comprehensive 2,400 page research study on COVID-19 therapeutic and vaccine pipeline candidates, completed, ongoing and planned clinical trials across phases, countries, companies and institutes/hospitals. The global COVID-19 market size outlook remains robust driven by huge potential for administration to 2 billion populations,...
314 pages •
By Global Industry Analysts
• Jan 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 16
- Influencer Pool: 1653
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing...
Drug Development
World
North America
APAC
Europe
Latin America
Cancer Incidence
Drug Approval
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.